Apontis Pharma AG (APPH.DE)
EUR 10.05
(0.0%)
EUR 10.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -12.6 Million | 11.01 Million | 3.43 Million | 1.45 Million | -238.07 Thousand |
| Net Income | -11.3 Million | 2.68 Million | -745.23 Thousand | -1.18 Million | -2.39 Million |
| Depreciation & Amortization | 1.9 Million | 1795.00 | 1.74 Million | 1.65 Million | 569.65 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -4.34 Million | 6.07 Million | -2.49 Million | 698.83 Thousand | 1.48 Million |
| Other non-cash items | 1.14 Million | 2.25 Million | 4.92 Million | 280.75 Thousand | 97.97 Thousand |
| Investing Cash Flow | -2.9 Million | -2.67 Million | -1.77 Million | -777.16 Thousand | -1.38 Million |
| Investments in PPE | -3.26 Million | -3.27 Million | -1.65 Million | -729.56 Thousand | -1.05 Million |
| Acquisitions | 3.25 Million | -3.12 Million | - | - | -269.68 Thousand |
| Investment purchases | -57.85 Thousand | -53 Thousand | -121.63 Thousand | -48 Thousand | -69.1 Thousand |
| Sales/Maturities of investments | 55.9 Thousand | 34.1 Thousand | - | - | 1.04 Million |
| Other Investing Activities | -2.89 Million | 3.74 Million | 8137.40 | 400.42 | -1.04 Million |
| Financing Cash Flow | 6 Million | -1.83 Million | 20.12 Million | -1641.86 | -2079.74 |
| Debt repayment | -6 Million | - | -12.25 Million | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -1.83 Million | - | - | - |
| Common Stock Issuance | - | -1.83 Million | 38 Million | - | - |
| Other Financing Activities | -142.08 | 1.83 Million | -5.62 Million | - | - |
| Accounts receivables | - | -2.36 Million | 624.41 Thousand | -594.95 Thousand | 2.47 Million |
| Accounts payables | -722.59 Thousand | 2.36 Million | -624.41 Thousand | 594.95 Thousand | -2.47 Million |
| Inventory | -2.17 Million | 2.1 Million | -3.31 Million | 1.16 Million | 3.57 Million |
| Other working capital | -2.17 Million | 3.96 Million | 824.1 Thousand | -462.28 Thousand | -2.09 Million |
| Cash at beginning of period | 36.34 Million | 29.84 Million | 8.05 Million | 7.38 Million | 9.01 Million |
| Cash at end of period | 26.8 Million | 36.34 Million | 29.84 Million | 8.05 Million | 7.38 Million |
| Capital Expenditure | -3.26 Million | -3.27 Million | -1.65 Million | -729.56 Thousand | -1.05 Million |
| Effect of forex changes on cash | -45.02 Thousand | -0.76 | 0.36 | - | - |
| Net cash flow / Change in cash | -9.54 Million | 6.5 Million | 21.78 Million | 672.2 Thousand | -1.62 Million |
| Free Cash Flow | -15.86 Million | 7.74 Million | 1.77 Million | 721.44 Thousand | -1.28 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 702.79 Thousand | -11.3 Million | -7.78 Million | -3.52 Million | 337.55 Thousand | 2.68 Million |
| Depreciation & Amortization | 1.15 Million | 1.9 Million | 943.87 Thousand | 940.6 Thousand | 935.99 Thousand | 1795.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1 Million | -4.34 Million | 206.36 Thousand | -3.1 Million | 2.88 Million | 6.07 Million |
| Other non-cash items | -3.38 Million | 1.14 Million | 4.7 Million | -160 Thousand | 3.29 Million | 2.25 Million |
| Investing Cash Flow | -664.63 Thousand | -2.9 Million | -2.01 Million | -1.24 Million | -1.04 Million | -2.67 Million |
| Investments in PPE | -627.96 Thousand | -3.26 Million | -2 Million | -1.26 Million | -1.56 Million | -3.27 Million |
| Acquisitions | - | 3.25 Million | - | - | - | -3.12 Million |
| Investment purchases | -36.67 Thousand | -57.85 Thousand | -16.73 Thousand | -41.12 Thousand | 71.08 Thousand | -53 Thousand |
| Sales/Maturities of investments | - | 55.9 Thousand | - | 55.9 Thousand | -95.22 Thousand | 34.1 Thousand |
| Other Investing Activities | - | -2.89 Million | - | -1.00 | 550 Thousand | 3.74 Million |
| Financing Cash Flow | -6.12 Million | 6 Million | 6 Million | - | -963.19 Thousand | -1.83 Million |
| Debt repayment | -6.12 Million | -6 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | 872.42 Thousand | -1.83 Million |
| Common Stock Issuance | - | - | - | - | -1.83 Million | -1.83 Million |
| Other Financing Activities | - | - | - | - | - | 1.83 Million |
| Accounts receivables | - | - | - | - | - | -2.36 Million |
| Accounts payables | 982.21 Thousand | -722.59 Thousand | 347.77 Thousand | -1.07 Million | 542.7 Thousand | 2.36 Million |
| Inventory | - | -2.17 Million | - | - | - | 2.1 Million |
| Other working capital | -1.98 Million | -2.17 Million | -141.41 Thousand | -2.03 Million | 2.33 Million | 3.96 Million |
| Cash at beginning of period | 26.81 Million | 36.34 Million | 26.3 Million | 36.34 Million | 32.22 Million | 29.84 Million |
| Cash at end of period | 16.15 Million | 26.8 Million | 26.81 Million | 26.3 Million | 36.34 Million | 36.34 Million |
| Capital Expenditure | -627.96 Thousand | -3.26 Million | -2 Million | -1.26 Million | -1.56 Million | -3.27 Million |
| Effect of forex changes on cash | - | -45.02 Thousand | -45.02 Thousand | - | -1.00 | -0.76 |
| Net cash flow / Change in cash | -10.65 Million | -9.54 Million | 512.03 Thousand | -10.04 Million | 4.12 Million | 6.5 Million |
| Free Cash Flow | -4.49 Million | -15.86 Million | -5.47 Million | -10.05 Million | 4.55 Million | 7.74 Million |
CSSXF
SUNTECK
KMAZ
SHAHALLOYS
UZAPF
AIML